Skip to main content
. 2016 May 17;311(1):L101–L110. doi: 10.1152/ajplung.00125.2016

Fig. 1.

Fig. 1.

Pretreatment of bronchial epithelial cells (BECs) with β2-agonists dose-responsively inhibits hog dust extract (HDE)-induced cytokine release. Cultured immortalized human bronchial epithelial (BEAS-2B; A) and primary human bronchial epithelial (NHBE; B) cells were exposed to various concentrations of the long-acting β2-agonist salmeterol or the short-acting β2-agonist salbutamol for 1 h and then to 5% HDE in the presence or absence of β2-agonist for an additional 24 h. Supernatant medium was analyzed for IL-6 and IL-8 levels by ELISA. Values are means ± SE for 3 (A) or 4 (B) independent experiments. *P < 0.05 vs. HDE alone (by 1-way ANOVA and Tukey's posttest).